Abstract

The Joint Graduate Program in Toxicology (JGPT), a cooperative effort of Rutgers University and the University of Medicine and Dentistry of New Jersey, was developed 20 years ago to meet the need for well-trained toxicologists to address threats to environmental and human health posed by chemicals. The program is centered in the Environmental and Occupational Health Sciences Institute, a facility dedicated to research and instruction in a wide range of environmental disciplines. To date, the JGPT has awarded 69 doctorates and 15 Master?s degrees. Of the 32 predoctoral students and 7 postdoctoral fellows currently in the JGPT, the training grant supports nine predoctoral and two postdoctoral fellows. Predoctoral trainees usually have strong backgrounds in biomedical disciplines or engineering. The educational emphasis has been on rigorous, multi-disciplinary training in contemporary mechanistic toxicology, which is now complemented by extensive experiential opportunities involving the latest biomedical technologies. The on-going goal of the JGPT is to continue to prepare talented toxicologists to assume leadership roles in academia, government, and industry.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Institutional National Research Service Award (T32)
Project #
5T32ES007148-19
Application #
6916212
Study Section
Environmental Health Sciences Review Committee (EHS)
Program Officer
Shreffler, Carol K
Project Start
1987-09-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
19
Fiscal Year
2005
Total Cost
$368,244
Indirect Cost

  Institution

Name
Rutgers University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
001912864
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901

  Publications

Joseph, Laurie B; Composto, Gabriella M; Perez, Roberto M et al. (2018) Sulfur mustard induced mast cell degranulation in mouse skin is inhibited by a novel anti-inflammatory and anticholinergic bifunctional prodrug. Toxicol Lett 293:77-81
Stapleton, P A; McBride, C R; Yi, J et al. (2018) Estrous cycle-dependent modulation of in vivo microvascular dysfunction after nanomaterial inhalation. Reprod Toxicol 78:20-28
Fournier, S B; D'Errico, J N; Stapleton, P A (2018) Engineered nanomaterial applications in perinatal therapeutics. Pharmacol Res 130:36-43
Botelho, Danielle; Leo, Bey F; Massa, Christopher et al. (2018) Exposure to Silver Nanospheres Leads to Altered Respiratory Mechanics and Delayed Immune Response in an in Vivo Murine Model. Front Pharmacol 9:213
George, Blessy; Joy, Melanie S; Aleksunes, Lauren M (2018) Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Exp Biol Med (Maywood) 243:272-282
Vail, Gwyndolin; Roepke, Troy A (2018) Membrane-initiated estrogen signaling via Gq-coupled GPCR in the central nervous system. Steroids :
Kohtz, Amy S; Lin, Belle; Smith, Michael E et al. (2018) Attenuated cocaine-seeking after oxytocin administration in male and female rats. Psychopharmacology (Berl) 235:2051-2063
Walley, Sabrina N; Roepke, Troy A (2018) Perinatal exposure to endocrine disrupting compounds and the control of feeding behavior-An overview. Horm Behav 101:22-28
Green, Ashley L; Zhan, Le; Eid, Aseel et al. (2017) Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1. Neuropharmacology 125:189-196
Beier, Eric E; Neal, Matthew; Alam, Gelerah et al. (2017) Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Neurobiol Dis 108:115-127

Showing the most recent 10 out of 166 publications